Viewing Study NCT06534268


Ignite Creation Date: 2025-12-24 @ 6:25 PM
Ignite Modification Date: 2026-01-04 @ 7:16 AM
Study NCT ID: NCT06534268
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-08-02
First Post: 2024-07-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study on Postoperative Adrenal Function Assessment in Patients With Primary Aldosteronism
Sponsor: Ruijin Hospital
Organization:

Study Overview

Official Title: Study on Postoperative Adrenal Function Assessment in Patients With Primary Aldosteronism
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study employs a prospective, single-center, open, observational research design to evaluate postoperative adrenal cortical function in patients with primary aldosteronism (PA) and to explore indicators predicting postoperative adrenal insufficiency and their predictive efficacy
Detailed Description: Patients suspected of having primary aldosteronism and admitted for treatment, who are diagnosed with primary aldosteronism through at least one confirmatory test, and subsequently diagnosed with unilateral primary aldosteronism via bilateral adrenal vein sampling and ACTH stimulation test, will undergo surgery. Those who have an ACTH stimulation test within one week postoperatively will be included in the study.

This study employs a prospective, single-center, open, observational research design to evaluate postoperative adrenal cortical function in patients with primary aldosteronism (PA) and to explore indicators predicting postoperative adrenal insufficiency and their predictive efficacy

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: